Search

Filters

Clear Filters
3:00 PM - 4:00 PM ET

2052 - Dosimetric Tolerances of the Brainstem and Anterior Optic Pathway to Re-Irradiation In Recurrent Gliomas
Speaker: Djavadian, Reza, MD, PhD - University of Alabama at Birmingham, Birmingham, AL
3:00 PM - 4:00 PM ET

2053 - Impact of Histology and Treatment Pathway in a 10-Year Radical-Intent Oesophageal Cancer Cohort
Speaker: Dobeson, Caroline, MB, ChB - The Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, Tyne and Wear
3:00 PM - 4:00 PM ET

2054 - Stereotactic Body Radiotherapy after Whipple Resection: Feasibility, Toxicity and Local Control
Speaker: Finton, Sarah, BA - David Geffen School of Medicine, Los angeles, CA
3:00 PM - 4:00 PM ET

2055 - Evaluation of Meningioma With 64Cu-DOTATATE PET: Initial Single-Institution Experience
Speaker: Elangovan, Vignesh, BS - Ohio State University College of Medicine, Columbus, OH
3:00 PM - 4:00 PM ET

2056 - Impact of Complete GTV Inclusion within =110% Isodose on Local Control and Toxicity after Spine Reirradiation SBRT
Speaker: Elguindy, Ahmed, MD - The Ohio State University James Cancer Hospital, Columbus, OH
3:00 PM - 4:00 PM ET

2057 - Discrepancies In Pancreatic Cancer Genomic Landscape between the Cancer Genome Atlas and a Large Single-Institution Database
Speaker: Ellsworth, Susannah, MD - University of Pittsburgh Cancer Centers, Pittsburgh, PA
3:00 PM - 4:00 PM ET

2058 - Stereotactic Body Radiotherapy (SBRT) in Unresectable Hepatocellular Carcinoma (HCC)- Prospective Study
Speaker: Engineer, Reena, MD - Tata Memorial Centre, Mumbai, Please Select
3:00 PM - 4:00 PM ET

2059 - Hypofractionated FLASH Carbon Ion Radiotherapy Outperforms Standard Dose-Rate Treatment in Genetically Engineered Pancreatic Cancer Models: Impact of Adaptive Immune Responses
Speaker: Moustafa, Mahmoud, DVM, PhD - German Cancer Research Center (DKFZ), Heidelberg, Baden-Wurt
11:15 AM - 11:25 AM ET

206 - Safety of Maintenance Pembrolizumab (Pembro) and Concurrent Radiotherapy (RT) in Pediatric Participants with Classic Hodgkin Lymphoma (cHL) and Slow Early Response (SER) to Front-Line Chemotherapy (Chemo): Post Hoc Analysis of the KEYNOTE-667 Study
Speaker: Hoppe, Bradford, MD, MPH, FASTRO - Mayo Clinic Florida, Jacksonville, FL
3:00 PM - 4:00 PM ET

2061 - Effect of Combined Deep Hyperthermia Therapy on Radiation Proctitis in Patients with Rectal Cancer Receiving Neoadjuvant Chemoradiotherapy: A Single-Center Case-Control Study
Speaker: Fan, Chunbo - chongqing uninersity cancer hospital, chongqing, chongqing
3:00 PM - 4:00 PM ET

2062 - Medium Dose of TPF Chemotherapy with Concurrent Radiotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma:A Prospective, Single Arm, Phase II Study (FUTURE-2)
Speaker: Fan, Xingwen, MD, PhD - Fudan University Shanghai Cancer Center, Shanghai, Shanghai
3:00 PM - 4:00 PM ET

2063 - Medium Dose of TPF Chemotherapy with Concurrent Radiotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Real-World Study
Speaker: Fan, Xingwen, MD, PhD - Fudan University Shanghai Cancer Center, Shanghai, Shanghai